Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma.
about
Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paragangliomaSafety and efficacy of tandem 131I-metaiodobenzylguanidine infusions in relapsed/refractory neuroblastoma.Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapyTherapeutic targets for neuroblastomas.Promising therapeutic targets in neuroblastomaDifferent outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG)Assessment of the efficacy and toxicity of (131)I-metaiodobenzylguanidine therapy for metastatic neuroendocrine tumoursPPARgamma in Neuroblastoma.Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastomaPhase I trial of 90Y-DOTATOC therapy in children and young adults with refractory solid tumors that express somatostatin receptorsIodine-131--metaiodobenzylguanidine double infusion with autologous stem-cell rescue for neuroblastoma: a new approaches to neuroblastoma therapy phase I study.The role of 131I-MIBG in high-risk neuroblastoma treatment.Radionuclide therapy of adrenal tumors.Correlation of Somatostatin Receptor-2 Expression with Gallium-68-DOTA-TATE Uptake in Neuroblastoma Xenograft Models.Modeling combined radiopharmaceutical therapy: a linear optimization framework.
P2860
Q33385556-704E12F9-3ED0-4B17-A649-D179364EEBBDQ33394925-1448C08E-5DC4-466F-BB66-74CD59126C28Q34543646-66A30CDA-D11F-47B8-983B-03101734559FQ34560877-2519EDB1-2508-4FFE-82F5-A5358142734EQ36055313-DEFE6E02-1323-40C6-8B31-AA90812681BDQ36167173-2EA79510-2563-4B03-BA2D-64309F324DA1Q36510103-8877120D-582E-4FB5-B5D6-993E9E811BF3Q36678476-C68A087A-91D0-45E0-BBC8-CE5B6CFBBF36Q37078231-AD5B2A73-FB6E-461D-8CAA-69ADC95BC76DQ37122608-B8C5A35C-E192-4E17-91A8-B5676288A040Q37334748-E791569F-1585-4947-9BC6-21ABC75047C8Q37591069-E6141322-3C37-4A2D-8527-019DC624EB66Q38020428-F68C1B48-7B02-42D6-B80D-CAD657CAFA7CQ43376054-2B5ABBF7-F3B4-412D-A298-6CF7E98E9854Q46149964-BB3FF84A-A18D-475B-B49A-97E8F51A108F
P2860
Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Tumor response and toxicity wi ...... for refractory neuroblastoma.
@ast
Tumor response and toxicity wi ...... for refractory neuroblastoma.
@en
type
label
Tumor response and toxicity wi ...... for refractory neuroblastoma.
@ast
Tumor response and toxicity wi ...... for refractory neuroblastoma.
@en
prefLabel
Tumor response and toxicity wi ...... for refractory neuroblastoma.
@ast
Tumor response and toxicity wi ...... for refractory neuroblastoma.
@en
P2093
P356
P1476
Tumor response and toxicity wi ...... for refractory neuroblastoma.
@en
P2093
James P Howard
John M Maris
John P Huberty
Katherine K Matthay
Leslie S Kersun
Randall A Hawkins
Su-Chun Cheng
P304
P356
10.1002/PBC.20240
P577
2005-03-01T00:00:00Z